Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 21(23)2020 Nov 24.
Article in English | MEDLINE | ID: mdl-33255418

ABSTRACT

Detection of early-stage hepatocellular carcinoma (HCC) is beneficial for prolonging patient survival. However, the serum markers currently used show limited ability to identify early-stage HCC. In this study, we explored human serum N-glycans as sensitive markers to diagnose HCC in patients with cirrhosis. Using a simplified fluorescence-labeled N-glycan preparation method, we examined non-sialylated and sialylated N-glycan profiles from 71 healthy controls and 111 patients with hepatitis and/or liver cirrhosis (LC) with or without HCC. We found that the level of serum N-glycan A2G1(6)FB, a biantennary N-glycan containing core fucose and bisecting GlcNAc residues, was significantly higher in hepatitis C virus (HCV)-infected cirrhotic patients with HCC than in those without HCC. In addition, A2G1(6)FB was detectable in HCV-infected patients with early-stage HCC and could be a more accurate marker than alpha-fetoprotein (AFP) or protein induced by vitamin K absence or antagonists-II (PIVKA-II). Moreover, there was no apparent correlation between the levels of A2G1(6)FB and those of AFP or PIVKA-II. Thus, simultaneous use of A2G1(6)FB and traditional biomarkers could improve the accuracy of HCC diagnosis in HCV-infected patients with LC, suggesting that A2G1(6)FB may be a reliable biomarker for early-stage HCC patients.


Subject(s)
Carcinoma, Hepatocellular/blood , Liver Cirrhosis/blood , Liver Neoplasms/blood , Polysaccharides/blood , Adult , Aged , Biomarkers, Tumor/blood , Carcinoma, Hepatocellular/complications , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/virology , Early Detection of Cancer , Female , Hepacivirus/pathogenicity , Hepatitis C, Chronic/blood , Hepatitis C, Chronic/complications , Hepatitis C, Chronic/pathology , Hepatitis C, Chronic/virology , Humans , Liver Cirrhosis/complications , Liver Cirrhosis/pathology , Liver Cirrhosis/virology , Liver Neoplasms/complications , Liver Neoplasms/pathology , Liver Neoplasms/virology , Male , Middle Aged , alpha-Fetoproteins/metabolism
2.
J Neurosci Res ; 91(2): 178-86, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23172790

ABSTRACT

In chronic demyelinating lesions of the central nervous system, insufficient generation of oligodendrocytes (OLs) is not due to a lack of oligodendrocyte precursor cells (OPCs), because the accumulation of OPCs and premyelinating OLs can be observed within these lesions. Here we sought to identify the basis for the failure of OLs to achieve terminal differentiation in chronic demyelinating lesions through the utilization of plp1-overexpressing (Plp(tg/-)) mice. These mice are characterized by progressive demyelination in young adults and chronic demyelinating lesions at more mature stages. We show that neural stem cells, which are the precursors of OL-lineage cells, are present in the Plp(tg/-) mouse brain and that their multipotentiality and ability to self-renew are comparable to those of wild-type adults in culture. Lineage-tracing experiments using a transgenic mouse line, in which an inducible Cre recombinase is knocked in at the Olig2 locus, revealed that Olig2-lineage cells preferentially differentiated into OPCs and premyelinating OLs, but not into astrocytes, in the Plp(tg/-) mouse brain. These Olig2-lineage cells matured to express myelin basic protein but after that their processes degenerated in the chronic demyelinating lesions of the Plp(tg/-) brain. These results indicate that in chronic demyelinated lesions more OL-lineage cells are produced as part of the repair process, but their processes degenerate after maturation.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/metabolism , Cell Lineage/physiology , Demyelinating Diseases/physiopathology , Myelin Basic Protein/metabolism , Myelin Proteolipid Protein/metabolism , Nerve Tissue Proteins/metabolism , Oligodendroglia/physiology , Age Factors , Animals , Antineoplastic Agents, Hormonal/pharmacology , Basic Helix-Loop-Helix Transcription Factors/genetics , Brain/pathology , Cell Differentiation , Demyelinating Diseases/genetics , Demyelinating Diseases/metabolism , Demyelinating Diseases/pathology , Disease Models, Animal , Gene Expression Regulation, Developmental/drug effects , Gene Expression Regulation, Developmental/genetics , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Mice , Mice, Transgenic , Myelin Proteolipid Protein/genetics , Nerve Tissue Proteins/genetics , Neural Stem Cells/drug effects , Neural Stem Cells/physiology , Oligodendrocyte Transcription Factor 2 , Tamoxifen/pharmacology
3.
Biochem Biophys Res Commun ; 374(2): 219-25, 2008 Sep 19.
Article in English | MEDLINE | ID: mdl-18619944

ABSTRACT

Serum glycans are promising markers for early-stage cancer detection, but the research remains challenging because low concentrations of serum glycoproteins are secreted from early-stage tumors. We have established an N-glycan profiling method using liquid chromatography electrospray ionization-mass spectrometry with high sensitive derivative, trimethyl(4-aminophenyl)ammonium chloride (TMAPA). The mass sensitivity of TMAPA-labeled oligosaccharides was enhanced more than 50 times compared with 2-aminopyridine (PA) labeled oligosaccharides, and the analytical period was significantly shortened compared with traditional HPLC 2D-mapping. Using this method, we found about 28 major N-linked oligosaccharides in human sera, and we investigated their alterations in patients who developed hepatocellular carcinoma (HCC). We found that outer arm fucosylation (attached GlcNAc via an alpha 1-3/4 linkage) in highly branched oligosaccharides increased significantly in sera of HCC patients. Normalizing the level of outer arm fucosylation by taking into account platelet concentration allowed us to distinguish more clearly between HCC and LC patients.


Subject(s)
Biomarkers, Tumor/blood , Carcinoma, Hepatocellular/diagnosis , Chromatography, Liquid/methods , Fucose/metabolism , Liver Neoplasms/diagnosis , Polysaccharides/blood , Spectrometry, Mass, Electrospray Ionization/methods , Biomarkers, Tumor/metabolism , Carbohydrate Sequence , Carcinoma, Hepatocellular/blood , Diagnosis, Differential , Early Diagnosis , Humans , Liver Cirrhosis/blood , Liver Cirrhosis/diagnosis , Liver Neoplasms/blood , Molecular Sequence Data , Phenylenediamines/chemistry , Polysaccharides/metabolism , Quaternary Ammonium Compounds/chemistry
4.
Stem Cells ; 26(7): 1758-67, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18467661

ABSTRACT

Neural stem cells (NSCs) have attracted considerable attention as a potential source of cells for therapeutic treatment of impaired areas of the central nervous system. However, efficient and clinically feasible strategies for expansion of the endogenous NSC pool are currently unavailable. In this study, we demonstrate that mood stabilizing drugs, which are used to treat patients with bipolar disorder, enhance the self-renewal capability of mouse NSCs in vitro and that this enhancement is achieved at therapeutically relevant concentrations in the cerebrospinal fluid. The pharmacological effects are mediated by the activation of Notch signaling in the NSC. Treatment with mood stabilizers increased an active form of Notch receptor and upregulated its target genes in neural stem/progenitor cells, whereas coculture with gamma-secretase inhibitor or the presence of mutation in the presenilin1 gene blocked the effects of mood stabilizers. In addition, chronic administration of mood stabilizers expanded the NSC pool in the adult brain, which subsequently increased the cell supply to the olfactory bulb. We suggest that treatment with mood stabilizing drugs could be used to facilitate regeneration following insult to the central nervous system.


Subject(s)
Affect/drug effects , Antimanic Agents/therapeutic use , Brain/drug effects , Neurons/metabolism , Receptors, Notch/metabolism , Stem Cells/metabolism , Animals , Brain/metabolism , Cell Culture Techniques/methods , Male , Mice , Mice, Inbred C57BL , Mice, Inbred ICR , Olfactory Bulb/drug effects , Olfactory Bulb/metabolism , Presenilin-1/biosynthesis , Presenilin-1/genetics , Signal Transduction
5.
J Neurosci Res ; 85(16): 3574-85, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17668856

ABSTRACT

In rodents, adult neurogenesis occurs in the olfactory bulb and the dentate gyrus of the hippocampus. It has been shown that exposure to psychosocial stress reduces cell proliferation in the dentate gyrus. However, little is known about how stress affects the proliferation kinetics of neural stem cells (NSCs) in the subventricular zone (SVZ), which provide new neurons to the olfactory bulb. We utilized a forced-swim model of stress in the mouse and found that chronic stress decreased the number of NSCs in the SVZ. The reduction of NSC number persisted for weeks after the cessation of stress but was reversed by treatment with the antidepressant drugs fluoxetine and imipramine. We demonstrated by in vitro colony-forming neurosphere assay that corticosterone attenuated neurosphere formation by adult NSCs and, in contrast, that serotonin increased the survival of NSCs. In addition, serotonin expanded the size of the NSC pool in the SVZ when it was infused into the lateral ventricle in vivo. These results suggest that, under chronic stress conditions, the number of NSCs is regulated by the actions of glucocorticoids and serotonin. These data provide insights into the molecular mechanisms underlying the pharmacological actions of antidepressant drugs.


Subject(s)
Antidepressive Agents/pharmacology , Nerve Degeneration/drug therapy , Nerve Degeneration/etiology , Stem Cells/drug effects , Stress, Psychological/complications , Telencephalon/drug effects , Animals , Antidepressive Agents/therapeutic use , Biological Assay , Cell Death/drug effects , Cell Death/physiology , Cells, Cultured , Chronic Disease , Corticosterone/adverse effects , Disease Models, Animal , Fluoxetine/pharmacology , Fluoxetine/therapeutic use , Glucocorticoids/metabolism , Imipramine/pharmacology , Lateral Ventricles/cytology , Male , Mice , Mice, Inbred ICR , Nerve Degeneration/physiopathology , Olfactory Bulb/cytology , Olfactory Bulb/drug effects , Olfactory Bulb/physiopathology , Serotonin/metabolism , Serotonin/pharmacology , Selective Serotonin Reuptake Inhibitors/pharmacology , Spheroids, Cellular , Stem Cells/physiology , Swimming/psychology , Telencephalon/cytology , Telencephalon/physiopathology
6.
J Biol Chem ; 279(36): 37677-84, 2004 Sep 03.
Article in English | MEDLINE | ID: mdl-15231847

ABSTRACT

Previously we reported that AMAP2/PAG3/Papalpha/KIAA0400, a GTPase-activating protein (GAP), acts to antagonize Arf6 function when overexpressed, whereas it was shown to exhibit efficient GAP activities for other Arf isoforms in vitro. Here, we found that AMAP2, through its ArfGAP domain, binds to GTP-Arf6 but not to GDP-Arf6 or other Arfs irrespective of nucleotide status. The majority of AMAP2 was localized to intracellular tubulovesicular structures and redistributed to Arf6-enriched membrane areas upon Arf6 activation. In HeLa cells, Arf6 has been shown to be involved in the clathrin-independent endocytosis of Tac, but not the clathrin-dependent endocytosis of transferrin. We found that Arf6 silencing inhibited the internalization of Tac, but not transferrin, in HeLa cells. Internalization of Tac, but not transferrin, was also significantly inhibited by AMAP2 silencing and overexpression. AMAP2 was moreover found to bind to amphiphysin IIm, a component of the endocytic machinery, via its proline-rich domain. We propose that AMAP2 has dual mechanisms for its function; it exhibits efficient catalytic GAP activity for the class I and II Arfs and yet is involved in the cellular function of the class III Arf without immediate GAP activity. These dual mechanisms of AMAP2 may be important for the cellular function of GTP-Arf6.


Subject(s)
ADP-Ribosylation Factors/physiology , GTPase-Activating Proteins/physiology , ADP-Ribosylation Factor 6 , ADP-Ribosylation Factors/metabolism , Amino Acid Sequence , Animals , Base Sequence , COS Cells , DNA Primers , Endocytosis/physiology , GTPase-Activating Proteins/metabolism , HeLa Cells , Humans , Microscopy, Immunoelectron , Molecular Sequence Data , Nerve Tissue Proteins/metabolism , Protein Binding
7.
Proc Natl Acad Sci U S A ; 100(7): 4132-7, 2003 Apr 01.
Article in English | MEDLINE | ID: mdl-12642666

ABSTRACT

Sickness evokes various neural responses, one of which is activation of the hypothalamo-pituitary-adrenal (HPA) axis. This response can be induced experimentally by injection of bacterial lipopolysaccharide (LPS) or inflammatory cytokines such as IL-1. Although prostaglandins (PGs) long have been implicated in LPS-induced HPA axis activation, the mechanism downstream of PGs remained unsettled. By using mice lacking each of the four PGE receptors (EP1-EP4) and an EP1-selective antagonist, ONO-8713, we showed that both EP1 and EP3 are required for adrenocorticotropic hormone release in response to LPS. Analysis of c-Fos expression as a marker for neuronal activity indicated that both EP1 and EP3 contribute to activation of neurons in the paraventricular nucleus of the hypothalamus (PVN). This analysis also revealed that EP1, but not EP3, is involved in LPS-induced activation of the central nucleus of the amygdala. EP1 immunostaining in the PVN revealed its localization at synapses on corticotropin-releasing hormone-containing neurons. These findings suggest that EP1- and EP3-mediated neuronal pathways converge at corticotropin-releasing hormone-containing neurons in the PVN to induce HPA axis activation upon sickness.


Subject(s)
Adrenocorticotropic Hormone/metabolism , Endotoxins/toxicity , Lipopolysaccharides/toxicity , Paraventricular Hypothalamic Nucleus/physiology , Receptors, Prostaglandin E/deficiency , Receptors, Prostaglandin E/physiology , Synapses/physiology , Animals , Bacterial Infections , Corticotropin-Releasing Hormone/analysis , Cyclooxygenase 1 , Cyclooxygenase 2 , Gene Expression Regulation/drug effects , Genes, fos , Hypothalamo-Hypophyseal System/drug effects , Hypothalamo-Hypophyseal System/physiology , Isoenzymes/metabolism , Membrane Proteins , Mice , Mice, Knockout , Neurons/physiology , Pituitary-Adrenal System/drug effects , Pituitary-Adrenal System/physiology , Prostaglandin-Endoperoxide Synthases/metabolism , Receptors, Prostaglandin E/genetics , Receptors, Prostaglandin E, EP1 Subtype , Receptors, Prostaglandin E, EP2 Subtype , Receptors, Prostaglandin E, EP3 Subtype , Receptors, Prostaglandin E, EP4 Subtype , Reverse Transcriptase Polymerase Chain Reaction
8.
J Cell Biol ; 156(3): 555-65, 2002 Feb 04.
Article in English | MEDLINE | ID: mdl-11827984

ABSTRACT

The nectin-afadin system is a novel cell-cell adhesion system that organizes adherens junctions cooperatively with the cadherin-catenin system in epithelial cells. Nectin is an immunoglobulin-like adhesion molecule, and afadin is an actin filament-binding protein that connects nectin to the actin cytoskeleton. Nectin has four isoforms (-1, -2, -3, and -4). Each nectin forms a homo-cis-dimer followed by formation of a homo-trans-dimer, but nectin-3 furthermore forms a hetero-trans-dimer with nectin-1 or -2, and the formation of each hetero-trans-dimer is stronger than that of each homo-trans-dimer. We show here that at the synapses between the mossy fiber terminals and dendrites of pyramidal cells in the CA3 area of adult mouse hippocampus, the nectin-afadin system colocalizes with the cadherin-catenin system, and nectin-1 and -3 asymmetrically localize at the pre- and postsynaptic sides of puncta adherentia junctions, respectively. During development, nectin-1 and -3 asymmetrically localize not only at puncta adherentia junctions but also at synaptic junctions. Inhibition of the nectin-based adhesion by an inhibitor of nectin-1 in cultured rat hippocampal neurons results in a decrease in synapse size and a concomitant increase in synapse number. These results indicate an important role of the nectin-afadin system in the formation of synapses.


Subject(s)
Cell Adhesion Molecules/metabolism , Cell Adhesion/physiology , Cell Differentiation/physiology , Microfilament Proteins/metabolism , Mossy Fibers, Hippocampal/embryology , Pyramidal Cells/metabolism , Synapses/metabolism , Adherens Junctions/drug effects , Adherens Junctions/metabolism , Adherens Junctions/ultrastructure , Animals , Cell Adhesion/drug effects , Cell Adhesion Molecules/antagonists & inhibitors , Cell Differentiation/drug effects , Dendrites/metabolism , Dendrites/ultrastructure , Dose-Response Relationship, Drug , Fetus , Immunohistochemistry , Kinesins , Microscopy, Electron , Mossy Fibers, Hippocampal/metabolism , Mossy Fibers, Hippocampal/ultrastructure , Myosins , Nectins , Protein Structure, Tertiary/physiology , Pyramidal Cells/ultrastructure , Rats , Synapses/drug effects , Synapses/ultrastructure , Synaptic Membranes/metabolism , Synaptic Membranes/ultrastructure , Synaptophysin/pharmacology , Viral Envelope Proteins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...